Carmichael Hill & Associates, Inc. Brooklyn Immuno Therapeutics, Inc. Put Options Transaction History
Carmichael Hill & Associates, Inc.
- $279 Million
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding BTX
# of Institutions
1Shares Held
1.21MCall Options Held
0Put Options Held
0About Brooklyn ImmunoTherapeutics, Inc.
- Ticker BTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,825,700
- Description
- Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy techno...